Orellanine
N/A
Report date: 2026/04/25 20:00:23
NME
Base Information
Drug NameOrellanine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSahlgrenska University Hospital
China Registration ClassN/A
Develop Information
Active CompaniesOncorena AB
Inactive CompaniesSahlgrenska University Hospital
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksKEGG